It was supposed to be a quick fix—a cheeky experiment shared between two slim friends ahead of the summer holidays. Instead, Charlotte Griffiths, a healthy woman with a normal body mass index, found herself violently ill, mentally drained, and consumed by regret after taking just one dose of a prescription weight-loss injection designed for obese patients.
Charlotte’s story is becoming increasingly common in the UK, as the weight-loss drugs Wegovy and Ozempic, originally developed for people with obesity and type 2 diabetes, are now being misused by otherwise healthy individuals. Women at the school gates whisper about “Wegovy Wednesdays,” joking about who’s using “The Pen” to lose a few pounds before a vacation. But behind the giggles lies a rising health concern that experts say could have devastating consequences.
“I felt like I had poisoned myself,” said Charlotte, a journalist and mother of three. “The nausea was relentless. I was anxious, dizzy, and totally incapable of caring for my children.”
Despite having a BMI of 21.7, which falls at the lower end of the normal range, Charlotte succumbed to curiosity and peer pressure. One evening, while picking her daughter up from a playdate, she let her friend inject her with a full dose of Wegovy. Within hours, the side effects began to hit.
By morning, she was battling brain fog, vomiting, and an overwhelming sense of dread. The injection, meant to dull the appetite by mimicking the natural hormone GLP-1, had left her repulsed by food, water, and even toothpaste. She couldn’t walk her daughter to school, cancelled all her exercise classes, and was bedridden for days.
The dose Charlotte received turned out to be far too high for a first-time user. “You’re supposed to start at 0.25mg and build up slowly,” she later learned. Instead, she was given 1mg—the amount typically reached after months of gradual increases.
“I thought I could just have a fun, quick jab to get back into my pre-baby jeans,” she said. “But I ended up needing anti-nausea medication and emergency babysitters.”
And Charlotte is far from alone. Government figures show over 7,200 serious adverse reactions to weight-loss jabs have been reported in the UK since 2019. The drugs have also been linked to at least 20 deaths.
In one tragic case, Trish Webster, a 56-year-old woman in Australia, died after taking semaglutide to lose weight before her daughter’s wedding. She suffered constant vomiting, collapsed, and later died from what doctors described as “acute gastrointestinal illness,” possibly linked to intestinal blockage—a rare but known risk of the drug.
Other horror stories include Shannon Flannery, a 27-year-old who bought the drug online and ended up hospitalized with blood in her urine, and Stacey Smith, a mother of three who thought she was going to die after purchasing an illegal jab on Facebook.
Yet social media continues to glamorize the drugs. Influencers flaunt their shrinking waistlines, and celebrities like Elon Musk, Rebel Wilson, and Oprah Winfrey have publicly endorsed semaglutide-based treatments, fueling a dangerous trend where appearance trumps safety.
Doctors are sounding the alarm.
“These drugs are powerful tools for those who medically qualify,” said Professor David Strain of the University of Exeter. “But there is no clinical data on how they affect healthy, normal-weight individuals. We don’t know what damage they could do.”
Strain warns that misuse could alter hormone production, disrupt gut function, and even suppress the brain’s pleasure centers—leading to apathy, depression, or worse.
“If you don’t need it and take it anyway, you risk losing interest in everything—not just food,” he added.
Charlotte’s story is a stark reminder that weight-loss medication is not a harmless shortcut. Despite losing weight, she says she looks and feels worse than before. “The jeans I was desperate to fit into? I put them on—and took them off an hour later. They were just a reminder of how stupid I’d been.”
Experts now call for tighter regulation and better education. Professor Naveed Sattar, an obesity expert, says access should be strictly limited to patients who truly need the drug. “The NHS can’t even meet demand for approved patients. We can’t afford for vanity users to exploit the system.”
Charlotte has a simple message for those tempted to follow in her footsteps: “Don’t do it. Not for a holiday. Not for a dress. It’s just not worth it.”
What started as a “harmless” jab has become a cautionary tale. And for many women swept up in the Wegovy wave, the hangover is only just beginning.
